Gallstones And Cancer

The researchers published an article in the British Journal of Cancer "(British Journal of Cancer), said that the future risk for gallstones hospitalized patients the risk of fatal bile duct tumors is higher than the general population, but gallstone surgery to remove the The risk will come down gradually to normal levels. The bile ducts connect the liver, gallbladder and small intestine of the pipeline, cholangiocarcinoma refers bile duct cancer. Over the past decade, liver, endogenous tumor cases increased by nearly three times.

The study is based on Swedish national case database, tracking analysis from 1965 to 2008, 192,960 hospitalized gallstones patients and 345,251 received a cholecystectomy or gallstone removal surgery patients. About two-thirds of the patients were female.

Tracking within 6.4 years, 241 cases of gallstone patients suffering from cholangiocarcinoma; received cholecystectomy in patients with 325 cases of cholangiocarcinoma cases in 12 years. Patients in both groups, 30% of bile duct cancer occur within the liver, 70% occurred outside of the liver.

The study found that compared with the general population, patients with gallstones to suffer from two types of cancer risks are higher, of which men was three times higher for women is 2.5 times higher, and this high-risk still exists for 10 years.

Human microbial gene mapping will become a new tool in diagnosis and treatment

Research staff had to map out a comprehensive genetic map of the microorganisms first a sojourn in the healthy human body, opens up new possibilities for doctors to diagnose diseases and treat patients.
Announced on June 13 this results from the one aimed at better understanding plays a key role in the process, from digestion to infections and other bacteria and other microorganisms, by the U.S. National Institutes of Health (National Institutes of Health) funding, took five years, one of the results of a cost of $ 173 million of human microbial engineering "(Human Microbiome Project).

Scientists know that the stranger trillions of such microorganisms ─ ─ in fact, they outnumber human cells in the human body, both the ratio of 10:1. But until now, scientists still do not understand all types of bacteria, dwelling location and the distinction between different human difference and the same body in different locations.

St. Louis (St. Louis) Washington University School of Medicine (Washington University School of Medicine), children with digestion and director of nutrition Philip • Tal (Phillip Tarr), which involves 80 agencies, the project leader of about 200 researchers one, he said, "This is actually a new field of biology."

Piece of a new gene map will support some of the causes of a combination of genetic factors and human bacterial community changes in disease research.

University of California, San Francisco (the University of California) biologist Michael • Feishibahe,, (Michael Fischbach), said, "This research could lead to new therapies for Crohn's disease, inflammatory bowel disorders], diabetes and metabolic new treatments of the disease, as well as other diseases such as eczema, new therapies. "He was not involved in the project.

U.S. researchers made the super-aspirin efficacy Strong is about 25 times

U.S. researchers two aspirin derivatives mixed together to make a "super aspirin. The experimental results show that this new type of aspirin can inhibit the growth of more than ten kinds of cancer, and non-destructive mice normal cells. The researchers said the "super aspirin developed into drugs people are still a few years.

Derivatives of a mixture of
City College of New York researchers published this month, "American Chemical Society Drug Chemical Letters papers wrote that this new type of aspirin can inhibit colon cancer, pancreatic cancer, lung cancer, prostate cancer, breast cancer, leukemia and other 11 kinds of malignant cell growth, and not prejudicial to the normal cells.

This "super" aspirin called nitric oxide hydrogen sulfide (NOSH) aspirin, a mixture of previously developed two aspirin derivatives, a derivative of the release of nitric oxide, help protect the gastric mucosa, another release of hydrogen sulfide to enhance the ability of aspirin cancer.

The researchers found that mixing up of two kinds of derivatives more secure than any one alone; on anti-cancer effect in terms of a mixture of aspirin stronger than nitric oxide 1.5 times, 80 times stronger than the hydrogen sulfide aspirin.